We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Single-Use Needle with Suction Launched at MEDICA Trade Show

By HospiMedica International staff writers
Posted on 13 Nov 2017
Image: The single-use Diathermy Abbey Needle with Suction is designed to improve visibility at the surgical site during breast surgery (Photo courtesy of Single Use Surgical).
Image: The single-use Diathermy Abbey Needle with Suction is designed to improve visibility at the surgical site during breast surgery (Photo courtesy of Single Use Surgical).
Single Use Surgical (Cardiff, UK), a manufacturer of single-use fine surgical suctions, will be unveiling a pioneering single-use Diathermy Abbey Needle with Suction at MEDICA 2017. The device improves visibility at the surgical site during submucosal diathermy (SMD), turbinectomy and breast surgery, thereby helping surgeons improve the performance and outcomes during the procedures.

Single Use Surgical focuses on identifying difficult-to-clean surgical equipment and offering high quality, alternative single-use solutions. The company produces sterile and efficient instruments, which reduce the risk of cross-contamination, and has developed a wide range of specialist single-use suctions capturing the same look, feel and functionality as the reusable equivalent.

Unlike most other disposable instruments made out of aluminum, the company’s products are manufactured using stainless steel tubes and cater to various specialties including ENT, head and neck, gynecology, laparoscopy, general and vascular surgery.

Over 5,000 exhibitors from 68 countries will be presenting new products at MEDICA, the world's leading medical trade fair taking place in Düsseldorf, Germany, from November 13 to 16, 2017. Among them will be Single Use Surgical showcasing its single-use Diathermy Abbey Needle with Suction.

“The launch of this pioneering device means there is no need for separate suction. This prevents crowding the surgical site in smaller, harder-to-reach areas,” said Michael Denver, Export Manager. “It also offers targeted and effective smoke extraction and being single-use, means it reduces the risks associated with cross-contamination and unintentional patient burns from damaged insulation.”

Related Links:
Single Use Surgical

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
High-Precision QA Tool
DEXA Phantom
New
Ultrasound Needle Guidance System
SonoSite L25

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more